Risk factors of lymph node metastases with endometrial carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6353-6356

  Cetinkaya, Kadir ^a   Atalay, Funda ^a   Bacinoglu, Ahmet ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Endometrial carcinoma; Lymph node; Metastasis; Myometrial invasion; Risk factors

Indexed keywords

ADULT; AGED; CANCER GRADING; CANCER STAGING; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MYOMETRIUM; PATHOLOGY; PERITONEUM; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STROMA CELL; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MYOMETRIUM; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEUM; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROMAL CELLS; SURVIVAL RATE;

EID: 84906257090     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6353     Document Type: Article

References (25)

1. Abu-Rustum NR (2014). Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center. J Obstet Gynaecol Res, 40, 327-34.
2. Acmaz G, Aksoy H, Albayrak E, et al (2014). Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high risk group. Asian Pac J Cancer Prev, 15, 195-8.
3. Arango HA, Hoffman MS, Roberts WS, et al (2000). Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol, 95, 553-6.
4. Atalay F, Cetinkaya K, Bacinoglu A (2013). Is the 2009 FIGO staging system really valuable for stage I endometrial cancer? Eur J Gynaecol Oncol, 34, 556-8.
5. Benedetti Panici P, Basile S, Maneschi F, et al (2008). Systematic pelvic lymphadenectomy vs no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 100, 1707-16.
6. Ben-Shachar I, Pavelka J, Cohn DE, et al (2005). Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol, 105, 487-93.
7. Binesh F, Akhavan A, Behniafard N, Jalilian S (2014). Endometrial adenocarcinoma: clinicopathologic and survival characteristics in Yazd, Iran. Asian Pac J Cancer Prev, 15, 2797-801.
8. Case AS, Rocconi RP, Straughn JM Jr, et al (2006). A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol, 108, 1375-9.
9. Chan JK, Kapp DS (2007). Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol, 8, 831-41.
10. Chi DS, Barakat RR, Palayekar MJ, et al (2008). The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer, 18, 269-73.
11. Cragun JM, Havrilesky LJ, Calingaert B, et al (2005). Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol, 23, 3668-75.
12. Creasman WT, Morrow CP, Bundy BN, et al (1987). Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-41.
13. Creasman W (2009). Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet, 105, 109.
14. Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al (2012). Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol, 120, 1419-27.
15. Gallego JC, Porta A, Pardo MC, Fernandez C (2014). Evaluation of myometrial invasion in endometrial cancer: comparison of diffusion-weighted magnetic resonance and intraoperative frozen sections. Abdom Imaging. Apr 4. [Epub ahead of print].
16. Girardi F, Petru E, Heydarfadai M, Haas J, Winter R (1993). Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol, 49, 177-80.
17. Goudge C, Bernhard S, Cloven NG, Morris P (2004). The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer. Gynecol Oncol, 93, 536-9.
18. Hahn HS, Song HS, Lee IH, et al (2013). Magnetic resonance imaging and intraoperative frozen sectioning for the evaluation of risk factors associated with lymph node metastasis in endometrial cancer. Int J Gynecol Cancer, 23, 1411-6.
19. Kang S, Todo Y, Watari H (2014). Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients? J Obstet Gynaecol Res, 40, 322-6.
20. Mariani A, Webb MJ, Keeney GL, et al (2000). Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gyneco, 182, 1506-19.
21. Neubauer NL, Lurain JR (2011). The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol, 2011, 814649.
22. Park JY, Kim EN, Kim DY, et al (2008). Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol, 108, 486-92.
23. Todo Y, Sakuragi N (2013). Methodological considerations in the analysis of the therapeutic significance of lymphadenectomy in endometrial cancer. Taiwan J Obstet Gynecol, 52, 8-13.
24. Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90.
25. Zuurendonk LD, Smit RA, Mol BW, et al (2006). Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol, 32, 450-4.